VP

Venkateswararao Puppala

Active Director Director DIN 10516745
DIN 10516745 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkateswararao Puppala

Data last updated:

Venkateswararao Puppala is a Director at Vint Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10516745
Primary Designation Director
Industry Pharma
First Appointment 21 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vint Pharmaceuticals Private Limited U46497TS2024PTC182425
Director21 Feb 20242024Active

Board colleagues of Venkateswararao Puppala

NameDINCompanyDesignation
Lavanya Pillari Setti10516744Vint Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vint Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Venkateswararao Puppala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkateswararao Puppala

Venkateswararao Puppala currently holds 1 directorship: Vint Pharmaceuticals Private Limited (Director, since 21 Feb 2024).

Venkateswararao Puppala was first appointed on 21 Feb 2024 as Director at Vint Pharmaceuticals Private Limited.

The current boards of Venkateswararao Puppala's companies include Lavanya Pillari Setti (Vint Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available